Saphris (Asenapine) Market
Saphris (Asenapine) Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Saphris (Asenapine) Market Size and Growth
The Saphris (Asenapine) market is characterized by rising demand due to its efficacy in treating schizophrenia and bipolar disorder. Current estimates indicate a market size exceeding $500 million, driven by increasing patient populations and awareness. Competitive dynamics, pricing strategies, and regulatory factors are pivotal in shaping future growth trajectories.
Companies Covered (Covid 19 Impact Covered)
◍ Allergan plc (AbbVie Inc.)
◍ Merck & Co., Inc.
◍ Actavis Generics (Teva)
The Saphris (Asenapine) market features key players like Allergan plc (AbbVie Inc.), Merck & Co., and Actavis Generics (Teva). These companies contribute through product distribution, R&D, and generics, enhancing accessibility and driving growth. Sales revenue showcases their market strength, with AbbVie reporting over $15 billion in 2022.
Market Segmentation
By Application
Schizophrenia
Acute Mania
Others
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
